Early and short molecular diagnosis of cancer and infectious diseases is very important. BIONANOGEN is a point-of-care (POC) detection chip that enables early and short-term molecular diagnosis of cancer and infectious diseases, based on the detection of nucleic acid biomarkers in blood, urine, tissue, and similar clinical samples, as a result of joint approaches made to produce a suitable option in the world, early diagnosis, and screening of diseases and cancer and is working on the development of the device.